PHOTOPLETHYSMOGRAPHY BIOSENSORS MARKET ANALYSIS

Regional Analysis

Global Photoplethysmography (PPG) Biosensors Market – Regional Analysis

On the basis of region, the global photoplethysmography (PPG) biosensors market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold dominant position in the global photoplethysmography (PPG) biosensors market over the forecast period, owing to the product launches and approvals. For instance, on July 19, 2021, Masimo, a global medical technology company headquartered in California, announced the release of MX-7, its most recent and advanced rainbow Signal Extraction Technology (SET) board. MX-7 is designed for integration into the more than 200 multi-parameter monitors available from Masimo's more than 90 original equipment manufacturing (OEM) partners. It supports all 13 of Masimo's SET pulse oximetry and rainbow Pulse CO-Oximetry measurements in an advanced module re-engineered to reduce power requirements.

Moreover, due to product launches or approvals, Asia Pacific region is expected to witness a significant growth in global photoplethysmography (PPG) biosensors market over the forecast period. For instance, on July 13, 2020, Mitocon Biomed, founded by Jinang Dhami, a Biomedical Research Engineer, launched Oxysat, a purely Indian-made pulse oximeter with an 18-month replacement warranty, at an affordable price. Unlike others, the company offered quality assurance because it owns the procurement, manufacturing, and distribution.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa